Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. The Berlin-Frankfurt-Münster Study Group.
about
Factors associated with the time to next attack in neuromyelitis optica: accelerated failure time models with random effects.Prognostic factors of survival time after hematopoietic stem cell transplant in acute lymphoblastic leukemia patients: Cox proportional hazard versus accelerated failure time modelsAutologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission - long-term follow-up.The present role of bone marrow and stem cell transplantation in the therapy of children with acute leukemia.Allogeneic bone marrow transplantation for hematological malignancies--controversies and recent advances.In vivo infusion of anti-LFA-1 and anti-CD2 antibodies prevents graft failure after HLA partially incompatible bone marrow transplantation in children with high risk acute lymphoblastic leukaemia.A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group.Peripheral blood stem cell collection in children with acute leukemia: effectiveness of the 'DIAVE' mobilizing regimen.Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia.[Treatment of children and adolescents with relapsed ALL: therapy target long-term healing].Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: a collaborative study of the Children's Oncology Group and the CA survey of blood utilization in children and adolescents in a German university hospital.The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study.
P2860
Q35072715-6F154023-E87F-4044-9576-6228D42EC842Q37032432-AFC2079E-E287-484C-A2B3-2CAB1A35FFDBQ40624297-4F213E2F-1DD9-4D19-AC7E-E22B8033BC15Q41650739-063E438E-3B2B-4D19-B9BB-49806FF2FF56Q41668011-F9DC4FD3-0A83-46ED-91B5-6E46EC0D7B60Q41719636-258BC9A1-1F93-4C98-8A97-0078F828B46CQ44103814-21167C4E-B319-4232-914B-CA61A045E3C7Q44170995-FEC450E0-6F48-4404-9531-B0E024D54C7AQ47349585-D2BF9516-ECC2-497B-A707-5FDCC3179A9CQ52887374-2C4FD230-48A5-4BA0-889E-CA011DFC5002Q53225240-8AB471A5-DA7E-43B3-9F48-79726AB01BAFQ53350706-7352DD1E-D2D7-462C-8CDE-1ABFDAAB0383Q54056099-6DD6CB5C-2A7B-4962-8CAB-AC6148990EFE
P2860
Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. The Berlin-Frankfurt-Münster Study Group.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Autologous bone-marrow transpl ...... Frankfurt-Münster Study Group.
@en
Autologous bone-marrow transpl ...... Frankfurt-Münster Study Group.
@nl
type
label
Autologous bone-marrow transpl ...... Frankfurt-Münster Study Group.
@en
Autologous bone-marrow transpl ...... Frankfurt-Münster Study Group.
@nl
prefLabel
Autologous bone-marrow transpl ...... Frankfurt-Münster Study Group.
@en
Autologous bone-marrow transpl ...... Frankfurt-Münster Study Group.
@nl
P2093
P1433
P1476
Autologous bone-marrow transpl ...... Frankfurt-Münster Study Group.
@en
P2093
A Borgmann
E Baumgarten
R Hartmann
T Klingebiel
P304
P356
10.1016/S0140-6736(95)92710-7
P407
P577
1995-09-01T00:00:00Z